227 related articles for article (PubMed ID: 8989729)
1. Molecular mechanisms of glomerular injury in rat experimental membranous nephropathy (Heymann nephritis).
Kerjaschki D; Neale TJ
J Am Soc Nephrol; 1996 Dec; 7(12):2518-26. PubMed ID: 8989729
[TBL] [Abstract][Full Text] [Related]
2. Proteinuria in passive Heymann nephritis is associated with lipid peroxidation and formation of adducts on type IV collagen.
Neale TJ; Ojha PP; Exner M; Poczewski H; Rüger B; Witztum JL; Davis P; Kerjaschki D
J Clin Invest; 1994 Oct; 94(4):1577-84. PubMed ID: 7929834
[TBL] [Abstract][Full Text] [Related]
3. Pathogenetic concepts of membranous glomerulopathy (MGN).
Kerjaschki D
J Nephrol; 2000; 13 Suppl 3():S96-100. PubMed ID: 11132040
[TBL] [Abstract][Full Text] [Related]
4. The Heymann nephritis antigenic complex: megalin (gp330) and RAP.
Farquhar MG; Saito A; Kerjaschki D; Orlando RA
J Am Soc Nephrol; 1995 Jul; 6(1):35-47. PubMed ID: 7579068
[TBL] [Abstract][Full Text] [Related]
5. [Molecular pathogenesis of experimental membraneous glomerulonephritis (Heymann nephritis)].
Kerjaschki D
Pathologe; 1996 Jul; 17(4):262-8. PubMed ID: 8927592
[TBL] [Abstract][Full Text] [Related]
6. Increased urinary excretion of C5b-9 distinguishes passive Heymann nephritis in the rat.
Schulze M; Baker PJ; Perkinson DT; Johnson RJ; Ochi RF; Stahl RA; Couser WG
Kidney Int; 1989 Jan; 35(1):60-8. PubMed ID: 2651753
[TBL] [Abstract][Full Text] [Related]
7. Metabolic fate of monovalent and multivalent antibodies of Heymann nephritis following formation of surface immune complexes on glomerular epithelial cells.
Singh AK; Kasinath BS
Clin Exp Immunol; 1993 Dec; 94(3):403-11. PubMed ID: 8252800
[TBL] [Abstract][Full Text] [Related]
8. Antibodies to glycolipids activate complement and promote proteinuria in passive Heymann nephritis.
Susani M; Schulze M; Exner M; Kerjaschki D
Am J Pathol; 1994 Apr; 144(4):807-19. PubMed ID: 8160779
[TBL] [Abstract][Full Text] [Related]
9. Induction of Heymann nephritis with a gp330/megalin fusion protein.
Raychowdhury R; Zheng G; Brown D; McCluskey RT
Am J Pathol; 1996 May; 148(5):1613-23. PubMed ID: 8623929
[TBL] [Abstract][Full Text] [Related]
10. Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis.
Exner M; Susani M; Witztum JL; Hovorka A; Curtiss LK; Spitzauer S; Kerjaschki D
Am J Pathol; 1996 Oct; 149(4):1313-20. PubMed ID: 8863678
[TBL] [Abstract][Full Text] [Related]
11. Megalin (gp330) possesses an antigenic epitope capable of inducing passive Heymann nephritis independent of the nephritogenic epitope in receptor-associated protein.
Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1995 Jul; 6(1):61-7. PubMed ID: 7579071
[TBL] [Abstract][Full Text] [Related]
12. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
Makker SP; Tramontano A
J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of immune-deposit formation and the mediation of immune renal injury.
Nangaku M; Couser WG
Clin Exp Nephrol; 2005 Sep; 9(3):183-91. PubMed ID: 16189625
[TBL] [Abstract][Full Text] [Related]
14. Role of receptor-associated 39/45 kD protein in active Heymann nephritis.
Huang J; Makker SP
Kidney Int; 1995 Feb; 47(2):432-41. PubMed ID: 7723231
[TBL] [Abstract][Full Text] [Related]
15. All four putative ligand-binding domains in megalin contain pathogenic epitopes capable of inducing passive Heymann nephritis.
Yamazaki H; Ullrich R; Exner M; Saito A; Orlando RA; Kerjaschki D; Farquhar MG
J Am Soc Nephrol; 1998 Sep; 9(9):1638-44. PubMed ID: 9727372
[TBL] [Abstract][Full Text] [Related]
16. Initial events in the formation of immune deposits in passive Heymann nephritis. gp330-anti-gp330 immune complexes form in epithelial coated pits and rapidly become attached to the glomerular basement membrane.
Kerjaschki D; Miettinen A; Farquhar MG
J Exp Med; 1987 Jul; 166(1):109-28. PubMed ID: 2885390
[TBL] [Abstract][Full Text] [Related]
17. Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.
Kerjaschki D; Exner M; Ullrich R; Susani M; Curtiss LK; Witztum JL; Farquhar MG; Orlando RA
J Clin Invest; 1997 Nov; 100(9):2303-9. PubMed ID: 9410908
[TBL] [Abstract][Full Text] [Related]
18. Induction of passive Heymann nephritis with antibodies specific for a synthetic peptide derived from the receptor-associated protein.
Kerjaschki D; Ullrich R; Exner M; Orlando RA; Farquhar MG
J Exp Med; 1996 May; 183(5):2007-15. PubMed ID: 8642311
[TBL] [Abstract][Full Text] [Related]
19. [The immune complex pathogenesis of experimental membranous glomerulopathy (Heymann nephritis) and its significance in human glomerular disease].
Kerjaschki D
Verh Dtsch Ges Pathol; 1989; 73():24-35. PubMed ID: 2482609
[TBL] [Abstract][Full Text] [Related]
20. Cytochrome P450 2B1 mediates complement-dependent sublytic injury in a model of membranous nephropathy.
Liu H; Tian N; Arany I; Bigler SA; Waxman DJ; Shah SV; Baliga R
J Biol Chem; 2010 Dec; 285(52):40901-10. PubMed ID: 20947506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
